Mitotane Concentrations Influence Outcome in Patients with Advanced Adrenocortical Carcinoma

Mitotane is the main option of treatment for advanced adrenocortical carcinoma (ACC). However, limited evidence is available regarding the impact of plasma mitotane levels on patient outcome. To address this question, we retrospectively analyzed patients with advanced ACC treated with mitotane for ≥...

Descripción completa

Detalles Bibliográficos
Autores principales: Puglisi, Soraya, Calabrese, Anna, Basile, Vittoria, Ceccato, Filippo, Scaroni, Carla, Altieri, Barbara, Della Casa, Silvia, Loli, Paola, Pivonello, Rosario, De Martino, Maria Cristina, Canu, Letizia, Russo, Marco, Badalamenti, Giuseppe, Torlontano, Massimo, Stigliano, Antonio, Ferraù, Francesco, Arnaldi, Giorgio, Saba, Laura, Quirino, Alessandra, Perotti, Paola, Berchialla, Paola, Terzolo, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140087/
https://www.ncbi.nlm.nih.gov/pubmed/32245135
http://dx.doi.org/10.3390/cancers12030740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140087/
https://www.ncbi.nlm.nih.gov/pubmed/32245135
http://dx.doi.org/10.3390/cancers12030740

Ejemplares similares